1. $NTES hod above ma-50 . bullish chart

  2. $NTES looking very strong

  3. $NTES if so...

  4. Scan results - 50 DMA Resistance today: $BLCM $STAR $AMH $IM $NTES $LKQ $SCTY $MIK $WTR $EQY ... http://swingtradebot.com/events/19/equities?selected_date=2015-03-31

  5. $NTES vs. $AKAM vs. $RAX vs. $VRSN Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=NTES|AKAM|RAX|VRSN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  6. CCI Over 100 http://www.dailystockplays.com/CCI-Over-100-2015-03-27.html $TDG $WBC $ALV $LII $NTES $RH $LANC $KOLD $MORN $OSIS $ATNI $AOS $HEI $IPHS $UFPI $CUB $NCLH $UIL $ADPT

  7. The majority of users on Vetr are bullish on Netease Inc, indicating a SELL Rating (2.5 stars) for $NTES https://www.vetr.com/research/NASDAQ:NTES/ratings

  8. Will have more on $BIDU before the open, but some of the possible concerns on horizon — $QIHU $NTES $CTRP #china

  9. $TWTR vs. $NTES vs. $ELNK Compared Across 9 Critical Measures Full Chart: http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=TWTR|NTES|ELNK&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  10. $LNKD vs. $AKAM vs. $NTES Compared Across 9 Critical Measures Full Chart: http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=LNKD|AKAM|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  11. $LNKD vs. $AKAM vs. $NTES Compared Across 9 Critical Measures Full Chart: http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=LNKD|AKAM|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  12. $TWTR vs. $QIHU vs. $NTES Compared Across 9 Critical Measures Full Chart: http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=TWTR|QIHU|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  13. Vetr users have downgraded Netease Inc to a SELL Rating (2.5 stars), giving $NTES a target price of $100.55 https://www.vetr.com/research/NASDAQ:NTES/ratings

  14. $KNDI ir fIRM CLIENT = $ntes

  15. $NTES Last Signal SHORT T 100.04 - issued by Yamasuta.com - Free Algorithmic Software - Free Until Jan 1st, 2016

  16. $LNKD vs. $NTES vs. $AOL Compared Across 9 Critical Measures Full Chart: http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=LNKD|NTES|AOL&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  17. NetEase downgraded by Vetr Inc. to sell. $100.55 PT. http://www.analystratings.net/stocks/NASDAQ/NTES/?RegistrationCode=SocialMedia-direct $NTES

  18. $TWTR vs. $SOHU vs. $NTES Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=TWTR|SOHU|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  19. $NTES Assets Rising http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=NTES&financial_bar=Assets+(US$+Millions)&financial_line=Assets+(US$+Millions)&start_date=06/30/2000&end_date=09/30/2014&show_line=false&sk=dfe3b2e75ef8873dd48ad4c64d314c83

  20. $AKAM vs. $RAX vs. $NTES Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AKAM|RAX|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  21. $LNKD vs. $EQIX vs. $NTES Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=LNKD|EQIX|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  22. $AKAM vs. $LNKD vs. $NTES Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AKAM|LNKD|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  23. $TWTR vs. $CMPR vs. $NTES Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=TWTR|CMPR|NTES&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  24. $AKAM vs. $NTES vs. $SOHU Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=AKAM|NTES|SOHU&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  25. $NTES Trade setup video https://www.youtube.com/watch?v=j-CzFgKC3Vg